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Overview
Compared to univariate analysis of genome-wide association
(GWA) studies, machine learning–based models have been shown
to provide improved means of learning such multilocus panels of
genetic variants and their interactions that are most predictive of
complex phenotypic traits. Many applications of predictive
modeling rely on effective variable selection, often implemented
through model regularization, which penalizes the model com-
plexity and enables predictions in individuals outside of the
training dataset. However, the different regularization approaches
may also lead to considerable differences, especially in the number
of genetic variants needed for maximal predictive accuracy, as
illustrated here in examples from both disease classification and
quantitative trait prediction. We also highlight the potential pitfalls
of the regularized machine learning models, related to issues such
as model overfitting to the training data, which may lead to over-
optimistic prediction results, as well as identifiability of the
predictive variants, which is important in many medical applica-
tions. While genetic risk prediction for human diseases is used as a
motivating use case, we argue that these models are also widely
applicable in nonhuman applications, such as animal and plant
breeding, where accurate genotype-to-phenotype modeling is
needed. Finally, we discuss some key future advances, open
questions and challenges in this developing field, when moving
toward low-frequency variants and cross-phenotype interactions.
Introduction
Supervised machine learning aims at constructing a genotype–
phenotype model by learning such genetic patterns from a labeled
set of training examples that will also provide accurate phenotypic
predictions in new cases with similar genetic background. Such
predictive models are increasingly being applied to the mining of
panels of genetic variants, environmental, or other nongenetic
factors in the prediction of various complex traits and disease
phenotypes [1–8]. These studies are providing increasing evidence
in support of the idea that machine learning provides a
complementary view into the analysis of high-dimensional genetic
datasets as compared to standard statistical association testing
approaches. In contrast to identifying variants explaining most of
the phenotypic variation at the population level, supervised
machine learning models aim to maximize the predictive (or
generalization) power at the level of individuals, hence providing
exciting opportunities for e.g., individualized risk prediction based
on personal genetic profiles [9–11]. Machine learning models can
also deal with genetic interactions, which are known to play an
important role in the development and treatment of many
complex diseases [12–16], but are often missed by single-locus
association tests [17]. Even in the absence of significant single-loci
marginal effects, multilocus panels from distinct molecular
pathways may provide synergistic contribution to the prediction
power, thereby revealing part of such hidden heritability compo-
nent that has remained missing because of too small marginal
effects to pass the stringent genome-wide significance filters [18].
Multivariate modeling approaches have already been shown to
provide improved insights into genetic mechanisms and the
interaction networks behind many complex traits, including
atherosclerosis, coronary heart disease, and lipid levels, which
would have gone undetected using the standard univariate
modeling [2,19–22]. However, machine learning models also
come with inherent pitfalls, such as increased computational
complexity and the risk for model overfitting, which must be
understood in order to avoid reporting unrealistic prediction
models or over-optimistic prediction results.
We argue here that many medical applications of machine
learning models in genetic disease risk prediction rely essentially
on two factors: effective model regularization and rigorous model
validation. We demonstrate the effects of these factors using
representative examples from the literature as well as illustrative
case examples. This review is not meant to be a comprehensive
survey of all predictive modeling approaches, but we focus on
regularized machine learning models, which enforces constraints
on the complexity of the learned models so that they would ignore
irrelevant patterns in the training examples. Simple risk allele
counting or other multilocus risk models that do not incorporate
any model parameters to be learned are outside the scope of this
review; in fact, such simplistic models that assume independent
variants may lead to suboptimal prediction performance in the
presence of either direct or indirect interactions through epistasis
effects or linkage disequilibrium, respectively [23,24]. Perhaps the
simplest models considered here as learning approaches are those
based on weighted risk allele summaries [23,25]. However, even
with such basic risk models intended for predictive purposes, it is
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important to learn the model parameters (e.g., select the variants
and determine their weights) based on training data only;
otherwise there is a severe risk of model overfitting, i.e., models
not being capable of generalizing to new samples [5]. Represen-
tative examples of how model learning and regularization
approaches address the overfitting problem are briefly summa-
rized in Box 1, while those readers interested in their implemen-
tation details are referred to the accompanying Text S1. We
Figure 1. Performance of regularized machine learning models. Upper panel: Behavior of the learning approaches in terms of their predictive
accuracy (y-axis) as a function of the number of selected variants (x-axis). Differences can be attributed to the genotypic and phenotypic
heterogeneity as well as genotyping density and quality. (A) The area under the receiver operating characteristic curve (AUC) for the prediction of
Type 1 diabetes (T1D) cases in SNP data from WTCCC [118], representing ca. one million genetic features and ca. 5,000 individuals in a case-control
setup. (B) Coefficient of determination (R2) for the prediction of a continuous trait (Tunicamycin) in SNP data from a cross between two yeast strains
(Y2C) [44], representing ca. 12,000 variants and ca. 1,000 segregants in a controlled laboratory setup. The peak prediction accuracy/number of most
predictive variants are listed in the legend. The model validation was implemented using nested 3-fold cross-validation (CV) [5]. Prior to any analysis
being done, the data was split into three folds. On each outer round of CV, two of the folds were combined forming a training set, and the remaining
one was used as an independent test set. On each round, all feature and parameter selection was done using a further internal 3-fold CV on the
training set, and the predictive performance of the learned models was evaluated on the independent test set. The final performance estimates were
calculated as the average over these three iterations of the experiment. In learning approaches where internal CV was not needed to select model
parameters (e.g., log odds), this is equivalent to a standard 3-fold CV. T1D data: the L2-regularized (ridge) regression was based on selecting the top
500 variants according to the x2 filter. For wrappers, we used our greedy L2-regularized least squares (RLS) implementation [30], while the embedded
methods, Lasso, Elastic Net and L1-logistic regression, were implemented through the Scikit-Learn [119], interpolated across various regularization
parameters up to the maximal number of variants (500 or 1,000). As a baseline model, we implemented a log odds-ratio weighted sum of the minor
allele dosage in the 500 selected variants within each individual [25]. Y2C: the filter method was based on the top 1,000 variants selected according to
R2, followed by L2-regularization within greedy RLS using nested CV. As a baseline model, we implemented a greedy version of least squares (LS),
which is similar to the stepwise forward regression used in the original work [44]; the greedy LS differs from the greedy RLS in terms that it
implements regularization through optimization of L0 norm instead of L2. It was noted that the greedy LS method drops around the point where the
number of selected variants exceeds the number training examples (here, 400). Lower panel: Overlap in the genetic features selected by the different
approaches. (C) The numbers of selected variants within the major histocompatibility complex (MHC) are shown in parentheses for the T1D data. (D)
The overlap among then maximally predictive variants in the Y2C data. Note: these results should be considered merely as illustrative examples.
Differing results may be obtained when other prediction models are implemented in other genetic datasets or other prediction applications.
doi:10.1371/journal.pgen.1004754.g001
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Box 1. Synthesis of Learning Models for
Genetic Risk Prediction
The aim of risk models is to capture in a mathematical form
the patterns in the genetic and non-genetic data most
important for the prediction of disease susceptibility. The
first step in model building involves choosing the
functional form of the model (e.g., linear or nonlinear),
and then making use of a given training data to determine
the adjustable parameters of the model (e.g., a subset of
variants, their weights, and other model parameters). While
it is often sufficient for a statistical model to enable high
enough explanatory power in the discovery material,
without being overly complicated, a predictive model is
also required to generalize to unseen cases.
One consideration in the model construction is how to
encode the genotypic measurements using genotype
models, such as the dominant, recessive, multiplicative,
or additive model, each implying different assumptions
about the genetic effects in the data [79]. Categorical
variables 0, 1, and 2 are typically used for treating genetic
predictor variables (e.g., minor allele dosage), while
numeric values are required for continuous risk factors
(e.g., blood pressure). Expected posterior probabilities of
the genotypes can also be used, especially for imputed
genotypes. Transforming the genotype categories into
three binary features is an alternative way to deal with
missing values without imputation (used in the T1D
example; see Text S1 for details).
Statistical or machine learning models identify statistical or
predictive interactions, respectively, rather than biological
interactions between or within variants [12,80]. While
nonlinear models may better capture complex genetic
interactions [7,81], linear models are easier to interpret and
provide a scalable option for performing supervised
selection of multilocus variant panels at the genome-wide
scale [3]. In linear models, genetic interactions are modeled
implicitly by selecting such variant combinations that
together are predictive of the phenotype, rather than
considering pairwise gene–gene relationships explicitly.
Formally, trait yi to be predicted for an individual i is
modeled as a linear combination of the individual’s
predictor variables xij:
yi~w0z
Xp
j~1
wjxij i~1,2, . . . ,n: ð1Þ
Here, the weights wj are assumed constant across the n
individuals, w0 is the bias offset term and p indicates the
number of predictors discovered in the training data. In its
basic form, Eq. 1 can be used for modeling continuous
traits y (linear regression). For case-control classification,
the binary dependent variable y is often transformed using
a logistic loss function, which models the probability of a
case class given a genotype profile and other risk factor
covariates x (logistic regression). It has been shown that
the logistic regression and naı¨ve Bayes risk models are
mathematically very closely related in the context of
genetic risk prediction [81].
Model regularization refers to the technique of controlling
the model complexity, with the aim of preventing over-
fitting the model to the training data, and hence to
improve its generalization capability to new samples.
Classical regularization approaches rely on explicit penal-
ization of the model complexity through penalty terms
such as L1 and L2 norms for model weights (Figure 2A).
Together with the squared loss function (Figure 2B), which
is often used to measure the fit between the observed yi
and estimated y^i phenotypes (Eq.1), these functional
norms give rise to the optimization problem used in
various types of linear genetic risk prediction models:
Squared loss L1 penalty L2 penalty
Xn
i~1
yi{y^ið Þ2zl1
Xp
j~1
wj
 zl2
Xp
j~1
w2j :
ð2Þ
Ridge regression is the special case of Eq. 2, in which
l1~0, and the regularization parameter l2 is used to
shrink the variable weights toward zero to prevent any
particular variable from having too large effect on the
model. However, the use of L2 penalty alone tends to favor
models that depend on all the variables. In Lasso, l2~0,
and through adjusting the regularization parameter l1, it is
possible to favor sparse models with only a few nonzero
weights, leading to variable selection within the model
fitting [82]. The Elastic Net model makes use of both
penalty terms L1 and L2 to select also correlated features
[83]; for instance, groups of variants within a pathway that
together contribute to the predictive accuracy.
Methods such as Lasso and Elastic Net are traditionally
known as embedded models, since the feature selection is
embedded into the learning algorithm itself [5]. These
methods select the features simultaneously and therefore
do not provide the user with a direct control over the
number of variables to be selected in the final prediction
model, although heuristics based on absolute weights and
other tuning criterion can be used for ranking the variables
[24,84]. In contrast, wrapper models enable the user to
preset the number of features in the final model. However,
due to the exponentially increasing size of the genetic
search spaces, in practice one must resort to local search
methods, such as greedy feature selection implemented
e.g., in L2-RLS wrappers [30].
The wrapper and embedded methods are not distinct
classes of algorithms. Scalable wrappers often incorporate
elements of embedded methods to guarantee computa-
tional efficacy. For instance, RLS shares similar properties
with Lasso and linear variants of SVMs. The accompanying
Text S1 describes interrelationships between different
learning models in terms of their norms and loss functions
(Figure 2), including squared loss (RLS, Lasso and Elastic
Net), logistic loss (logistic regression) and hinge loss
(SVMs). It also presents a generic optimization framework
that implements some of the most efficient methods
currently available for genome-wide data. There are also
other implementations available, including Mendel [85],
HyperLasso [86] and SparSNP [87], gpu-lasso [88], and
PUMA [89].
In addition to the classical regularization approaches,
where an explicit model complexity penalization term is
included in the optimization problem (Eq. 2), alternative
strategies have been developed for avoiding overfitting.
Among the most popular ones are ensemble learning,
implemented e.g., in the popular Random Forests (RF)
algorithm [90–92], as well as in the Bayesian modeling
approaches, where probabilistic prior distributions on the
model parameters are used for the shrinkage and
regularization purposes [93–95]. Other approaches are
based on the ensemble of models composed of varying
number of features [96], bagging or boosting and various
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specifically promote here the use of such regularized machine
learning models that are scalable to the entire genome-wide scale,
often based on linear models, which are easy to interpret and also
enable straightforward variable selection. Genome-scale ap-
proaches avoid the need of relying on two-stage approaches [26],
which apply standard statistical procedures to reduce the number
of variants, since such prefiltering may miss predictive interactions
across loci and therefore lead to reduced predictive performance
[8,24,25,27,28].
Preview: Selection of Genetic Variants into the
Predictive Models
A recent perspective article gave an excellent overview of the
common concepts and potential pitfalls when making predictions
of complex phenotypes using genotypic data [28]; however, one of
the key components in the construction of predictive models—
variant selection—was ignored in this and many other previous
works. In the context of machine learning, a method known as
feature selection is commonly implemented to identify the subset of
variants having most predictive power for the particular pheno-
typic trait. The aims of feature selection include the reduction of
the dimensionality of the genetic search space, excluding
correlated variants without independent contribution to the
prediction, and facilitating the implementation of the final
prediction model, for instance, in clinical setup. Three main types
of feature selection methods have traditionally been considered in
the context of genetic predictors: filters, wrappers, and embedded
methods (Box 1). These methods have different characteristics in
terms of their computational complexities, potential to detect joint
effects between variants, and whether the feature selection is done
explicitly in the optimization process or implicitly through model
regularization, which make them more or less suitable for different
application cases [5–8].
A class of widely used filter approaches includes the standard
multilocus genetic risk models, where the risk alleles and their
weights are determined through single-locus statistical tests, such
as odds–ratio, x2, or Fisher’s exact text (so-called weighted risk
scores). While such standard models have provided relatively good
predictive accuracies, as assessed using simulation studies or
hypothetical effect size distributions [29], we argue here that it
makes sense to use machine learning both for selecting the subsets
of the most predictive genetic features as well as training the final
prediction model using regularized learning approaches [5,30].
The recent work of Chatterjee et al., where they estimated the
effect size distributions for various quantitative and disease traits,
highlighted the benefits gained from more holistic models that
make use of the whole spectrum of genetic variation toward
improving the predictive power of the genetic risk prediction
models [31]. By design, the performance of any prediction model
will depend on the sample size of the training set, as well as
heritability of the disease trait, its underlying genetic architecture,
and whether there is additional information available such as
family history [29–33].
Representative Examples of Supervised Predictive
Modeling Studies
Predictive modeling can be treated either as a classification
problem (e.g., disease prediction in a case-control setting) or as a
regression formulation (e.g., prediction of height in a general
population cohort). Regardless of the problem formulation,
however, the critical issue is how to guarantee that the model
estimated in the training sample enables generalization power on
search-based algorithms [3]. From the theoretical view-
point, however, all of these learning approaches can be
considered as different types of regularization approaches
[97–100].
Whereas classical, univariate filter methods evaluate the
relevance of each genetic feature independently of the
others, more advanced multivariate filters have also been
proposed, including the Relief family of approaches
[101]. The main advantage of the multivariate filters over
the univariate ones is that they can detect complex
relationships between multiple genetic features and also
yield smaller feature sets with less redundancy. Results
from the ReliefF runs can also be aggregated, similar to
ensemble learning, to yield more robust variant rankings
and identification of gene–gene interactions [102].
However, multivariate filters also have specific limita-
tions, such that their selection criteria are not directly
connected to the generalization capability of the final
prediction model, which may lead to suboptimal results
[103].
Even advanced machine learning methodologies have
been shown to be negatively affected by the presence
of population stratification, leading to either false
positives or false negative detections. To avoid the
need to cluster the data into smaller substrata accord-
ing to population structures, learning machines can be
complemented by information of such substructures
extracted using feature extraction methods, such as
EIGENSTRAT, PCA, or MDS [104]. Lasso has been
extended to account for population structures through
linear mixed models [105], which are gaining much
popularity in association studies [106]. Machine learn-
ing methods enable also the detection of population
substructures, for instance, by learning ensembles of
decision trees that are capable of accurately predicting
individual’s subcontinental ancestry [107].
Linkage disequilibrium (LD) tends to lead to the selection of
highly correlated genetic features when using unpenalized
modeling approaches [24]. A simple strategy is to select
SNPs in linkage equilibrium, but this cannot distinguish the
functionally relevant variants from the nonfunctional ones.
Alternative approaches have revised, for instance, the tree-
building process or importance measure calculation in RF
[108], or replaced the univariate split functions by
nonlinear multivariate split functions of contiguous SNPs,
modeled as decision trees, to better account for SNP
correlations [109]. Penalization strategies, such as ridge
regression, Lasso and RLS, allow the model to avoid
placing too much weight on potentially overfit variables in
the presence of LD, which can lead to improved selection
of causal variants [110,111].
Finally, whole-genome prediction (WGP) models fit all of
the genotyped variants of the genetic data onto ridge
regression type of linear models, such as genomic best
linear unbiased prediction (GBLUP) or its variants
[34,112]. WGP approach has been widely used in animal
and plant breeding applications [113–115] and, with
recent improvements, increasingly also in human genet-
ics [116,117]. However, imperfect LD between markers
and the causal loci can impose suboptimal prediction
accuracy of WGP, especially when analyzing unrelated
individuals, but this can be improved through variable
selection or other model regularization approaches [61].
Moreover, due to the lack of direct control for the
number of variants, WGP approaches are not optimal for
those applications in which the size of the genotyped
variant panel is limited.
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new sets of individuals using appropriate learning models and
regularization approaches. Another important issue is how to
evaluate and quantify the predictive performance of these models
using procedures such as cross validation (CV) and statistics such
as the area under the curve (AUC) or coefficient of determination
(R2) (Text S1). These factors are next highlighted using
representative examples from the recent literature [1–4,34,35],
where various machine learning models have been implemented to
gain insights and prediction capability beyond that obtained using
standard statistical analyses of single nucleotide polymorphism
(SNP) data.
In one of the first machine learning applications, Wei et al.
showed that support vector machines (SVM) and L2-regularized
(ridge) logistic regression enabled construction of a highly
predictive risk model for type 1 diabetes (T1D) using less than
500 variants that passed a relatively stringent prefiltering threshold
(p,1025) on a case-control GWA dataset [1]. In contrast, relying
merely on a collection of known T1D susceptibility loci led to poor
performance in the predictive setting. More specifically, when the
predictive accuracy was evaluated in terms of within-study 5-fold
CV, they obtained extremely good prediction power (AUC close
to 0.9). However, it is known that simple CV may lead to over-
optimistic results due to information leakage between the two
stages of the feature selection process [5]. Indeed, when the
predictive models were evaluated using totally independent
validation cohort, the between-study performance dropped
drastically (AUC 0.84 for SVM) [1], highlighting the importance
of independent samples in the model validation.
Recently, Wei et al. made use of larger sample sizes (.10,000
individuals), using variant data from 15 European countries for
risk prediction of Crohn’s disease (CD) and ulcerative colitis (UC)
[4]. They applied a custom Immunochip that provides a more
comprehensive catalog of both common variants and certain rare
variants missed in the first generation of GWA studies. Using a
relatively liberal threshold (p,1024), they preselected around
10,000 variants and applied regularized logistic regression with L1
penalty for sparse genetic risk modeling. In an independent
validation set from the meta-analysis cohort, the predictive models
achieved the best prediction performance reported for CD and
UC (AUCs of 0.86 and 0.83, respectively) so far. In contrast, the
simple odds–ratio-weighted genetic risk model showed relatively
poor results (AUC of 0.730 and 0.685, respectively). The study also
confirmed the projections from previous works [31–33], suggesting
that predictive accuracy is highly dependent on the sample sizes
and the spectrum of variants included in the model, in addition to
the heritability of the disease trait.
The final example comes from the regression formulation. With
the aim to explain a part of the missing heritability of height, Yang
et al. [34] went beyond the two-stage approach and fit a simple
linear regression model to all directly genotyped 294,831 variants
that passed their quality control. Using such a whole genome
prediction (WGP) approach, without any variant selection, the
authors were able to explain 45% of the phenotypic variation in
height in a cohort of approximately 4,000 European descents.
Similarly high R2 values were also confirmed in another study [35]
where the WGP approach was trained in an European cohort;
however, R2 values dropped dramatically when the fitted model
was applied to an independent validation dataset using 10-fold CV
(R2 ranging around 0.2, depending on the number of variants and
whether familial information was used) [35]. These studies
highlight the risk of overfitting to the training sample when no
feature selection or model regularization is used in the model
construction.
Prediction Performance Using Examples of Model
Regularization
To illustrate the similarities and differences in their behavior, we
ran a number of common regularization approaches on two
example datasets (Figure 1). In both datasets, the two embedded
methods, Lasso and Elastic Net, showed strikingly similar
prediction behavior, but needed a larger number of variants for
their peak performance, compared to the greedy regularized least-
squares (RLS) wrapper, which peaked much earlier but resulted in
Figure 2. Penalty terms and loss functions. (A) Penalty terms: L0-norm imposes the most explicit constraint on the model complexity as it
effectively counts the number of nonzero entries in the model parameter vector. While it is possible to train prediction models with L0-penalty using,
e.g., greedy or other types of discrete optimization methods, the problem becomes mathematically challenging due to the nonconvexity of the
constraint, especially when other than the squared loss function is used. The convexity of the L1 and L2 norms makes them easier for the optimization.
While the L2 norm has good regularization properties, it must be used together with either L0 or L1 norms to perform feature selection. (B) Loss
functions: The plain classification error is difficult to minimize due to its nonconvex and discontinuous nature, and therefore one often resorts to its
better behaving surrogates, including the hinge loss used with SVMs, the cross-entropy used with logistic regression, or the squared error used with
regularized least-squares classification and regression. These surrogates in turn differ both in their quality of approximating the classification error
and in terms of the optimization machinery they can be minimized with (Text S1).
doi:10.1371/journal.pgen.1004754.g002
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lower prediction accuracy. As was expected, the top performance
of the L2-regularized logistic (ridge) regression required a very
large number of features, while showing reduced accuracy at a
lower number of variants. Surprisingly, the popular L1-penalized
logistic model showed slightly suboptimal performance; although
its peak performance was similar to that of greedy RLS, it required
a much larger number of variants in these datasets. We note that
the relative behavior of these methods may well change in other
genetic datasets and applications. In line with the previous results
in CD and UC cases [4], the simple log odds-weighted risk model
also showed poor results in the T1D case. While for some other
traits such accuracies would be considered excellent, the high
heritability and dependence on the human leukocyte antigen
(HLA) region often leads to higher predictive performance for
T1D [1]. However, these accuracies are better than expected for a
sample of this size if the standard, nonmachine learning,
multilocus genetic models were utilized in the risk prediction [28].
The relatively small overlap in the selected features highlights
an interesting point that the models tend to select different panels
of variants while achieving rather similar prediction performance
(Figure 1C, D), suggesting that the selected variants may provide
complementary views of the genetic mechanisms behind the
phenotypes. In the T1D case, for instance, most of the variants
selected by the L2-logistic and greedy RLS were from the major
histocompatibility complex (MHC) region (95% and 67%,
respectively), in line with the previous studies [1,4], whereas Lasso
also selected novel variants mostly outside the MHC region (15%),
which may provide complementary information for the risk
assessment. This difference is likely due to its embedded nature;
Lasso selects variants simultaneously, rather than one at a time,
which often requires further optimization in applications where
the size of the variant panel is limited. As expected, the univariate
filters tend to select larger numbers of correlated features, since
they cannot consider interactions with already selected variants. At
the other extreme, greedy RLS selects relatively uncorrelated
variants while the embedded methods lie in between. These
example cases suggest that there is no golden rule for feature
selection, but that the model should be selected based on the
characteristics of the data and goals of the genetic application (e.g.,
whether small number of variants is preferred over the overall
predictive accuracy).
Perspective: Current Challenges and Emerging
Developments
While rare variants have been proposed as one explanation for
the missing heritability [36,37], there has been a divergence of
opinion over whether rare variants of large effect or common
variants of small effect are contributing most to the phenotypic
variability [38]. It has been suggested that incorporating low-
frequency or rare variants will make the disease risk prediction
increasingly more accurate [4,28,29,31]. However, recent reports
have shown only incremental impact of rare variants on disease
susceptibility and prediction of complex diseases, as evaluated at the
population level using either simulated data [39] or by sequencing of
known risk variants for autoimmune disease traits [40]. We believe
that a more systematic investigation of the variants across portions
of the allelic spectrum will likely contribute to explainingmore of the
missing heritability. While the presented machine learning
algorithms easily scale to a GWA level, the emerging sequencing
data, either from genotype imputation or whole-exome and genome
profiling, are posing new technical challenges, where parallelization
and cloud technologies for distributed memory and high-perfor-
mance computing will become increasingly important. Placing the
focus on individual-level predictions should help also with the low-
frequency variants shared only by a small portion of the individuals.
For instance, selection of the most robust variants was shown to
improve various prediction models, especially when the variants are
poorly tagged or have low minor allele frequency (MAF) [41]. Since
most rare variants are highly population-specific, it may be
necessary to borrow prior biological information from shared
regulatory regions, genes, or pathways, similar to the recent
collapsing methods for rare association analyses [42]. However,
improved model regularization options that allow more flexibility
and sparsity in the selected panels of variants across various
subgroups of individuals will likely be needed to deal with the rare
variants and to account for population stratification. Regularization
methods based on sparse group Lasso, for instance, can be extended
to rare variants and pathway-driven variant selection [22,43].
It has been argued that, even with increasingly large-scale and
dense genomic data, genetic prediction alone may still not reach the
accuracy regarded as clinically informative for the population at
large [18]. High-quality and controlled genetic data from model
organisms will likely give the first estimates on how much
sequencing data can really add to the predictive accuracy of
complex phenotypes [44,45]. Lessons from model organisms have
already shown that additional information originating from
environmental and stochastic factors, as well as from phenotypic
robustness and transgenerational effects, will be necessary for
accurate predictions at an individual level [46–48]. In particular,
gene expression should prove especially useful, since such interme-
diate phenotype captures both genetic and nongenetic contributions
to phenotypic variation [49]. For instance, epigenetic gene
expression variability of genetic interaction partners plays an
important role in explaining complex regulatory relationships,
characterized using concepts such as ‘‘epigenetic epistasis’’ [50] or
‘‘eQTL epistasis’’ [51]. Although modeling of gene expression
variability poses some technical challenges, similar to those already
encountered when modeling GWA datasets [52,53], incorporating
such continuous features into the disease prediction models should
be relatively straightforward. Adding the nongenetic information
will likely be instrumental when going toward less heritable diseases,
such as some cancer subtypes, which traditionally have been
challenging to predict using standard GWA approaches
[29,32,33,54–56]. Finally, including family medical history and
other clinical data from electronic health records should improve
the personal risk assessment models, as well as provide guidance on
lifestyle changes for those currently healthy individuals that have
increased genetic risk for the disease susceptibility [57,58].
An interesting question under debate is how many genetic
features should be incorporated into the prediction models
[3,28,31,59,60]. Although the WGP methods have been success-
fully applied in animal and plant breeding applications [61], these
are not suitable for applications in which the number of genetic
markers is constrained. In embedded models, the number of
features to be selected is often dependent on the regularization
parameter. However, in the current Lasso and Elastic Net
implementations, the user cannot explicitly specify the number
of variants to be included in the final model, but the selection of
final predictors often requires further grid searches or other tuning
options. Such lack of direct control over the size of the variant
panel may be an important practical consideration in medical
applications, where the size of the variant panel is often associated
with an additional cost, for instance, in disease screening
applications, or when the goal is to select a few of the variants
for follow-up experimentation, for instance, using functional
assays. Greedy feature selection offers full control to the user
and often leads to smaller panels of predictive, uncorrelated
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variants, which may be beneficial when the size of clinical assay is
limited. However, the trade-off is a slight drop in the overall
predictive accuracy (Figure 1), indicating that more in-depth and
effective wrapper selection strategies need to be implemented.
There are also other strategies to reduce the dimensionality of
genetic feature spaces using data transformations, such as principal
components analysis (PCA), multidimensional scaling (MDS),
partial least squares (PLS), or discrete wavelet transformation
(DWT), which may in some cases lead to improved predictive
accuracy [62]. However, rather than selecting combinations of
transformed features, feature selection on the original variant
space offers directly actionable modeling outcomes, such as a
selected set of predictive genetic loci for follow-up applications and
experimentation.
We envision a number of future directions for improvements in
disease risk prediction. One exciting development involves model-
ing of cross-phenotype interactions (pleiotropy). Many genetic
variants are associated with multiple disease phenotypes, particu-
larly across autoimmune diseases, cancers, and neuropsychiatric
disorders [63]. Statistical approaches have been suggested for
making use of the complementary information from multiple
phenotypes to gain power to detect small effects that would have
been missed if tested individually [64–65]. Bayesian learning
approaches seem particularly fitting for multivariate modeling of
pleiotropic associations, especially for the lower-frequency variants
where shared genetic features across individuals for any single
phenotype become increasingly rare [66–71]. We expect that
regularized machine learning models will also prove useful when
translating the subtle multivariant–multiphenotype relationships
into genetic risk prediction models. Modeling studies in yeast have
already shown that multiple phenotypic measurements enable
mapping of genetic interaction networks with distinct biological
processes across pathways [72]. Networks of genetic and/or physical
interactions may therefore serve as useful prior information for the
prediction models to move from variant-level features towards
pathway-level features [5,73–75]. Using such functional relation-
ships to assemble or collapse higher-level predictive features might
better account for the interindividual genetic variation at the lower
end of variant frequency. For instance, predictive subnetwork
modules could enable more robust personalized medicine strategies
by allowing that individuals with the same disease phenotype may
show interindividual genetic heterogeneity in the sense that their
disease predisposing variants may lie in distinct loci within the
shared pathways. Such advances will rely on the next generation of
machine learning models that can effectively deal with the
complexity arising from massive number of interactions between
rare and common genetic and nongenetic factors [76–78].
Conclusions
The current evidence contradicts the idea of a universally optimal
model across datasets and prediction applications; rather, the model
should be selected based on whether one is trying to achieve a
maximally predictive model without restricting the number or type of
variants, or whether the goal is to build a sufficiently predictive model
with a limited number of genetic and nongenetic features. This
highlights the importance of feature selection as a key component in
the construction of prediction models, whether it is done explicitly in
the optimization process (e.g., wrappers) or implicitly through the
model regularization (embedded models). One common finding is
that those variants not meeting the stringent genome-wide signifi-
cance levels may also contribute to the predictive signals when
combined in the multilocus prediction modes [2,4,24,25,27,28,
31,33]. Another consensus point is that regularized models often
outperform their unregularized counterparts [24], which was also
supported by our example results (Figure 1).
Regardless of the model used, however, careful evaluation of its
generalizability is critical for prediction applications. We encourage
using systematic and unbiased procedures, such as nested CV, for the
selection of genetic variables and other model parameters and for the
evaluation of the generalization performance of the model. The final
model construction and feature selection should be performed on the
complete set of samples using standard CV options. However, the
eventual predictive power must be assessed by implementing the final
model on a sufficiently large, representative, and independent test set
in order to avoid reporting over-optimistic prediction results. The
model evaluation also depends on the application case; for instance, if
the aim is to carry out disease screening in Finland, then a relatively
large Finnish population sample should be used both in the model
construction and validation.
Genetic risk prediction through supervised machine learning
models goes beyond the single-locus association testing with the
complex disease phenotypes. The main objective of regularized
learning approaches is to find the most predictive combinations of
variants, the functional roles of which must to be validated using
follow-up experimentation. However, it is likely that predictive
power is linked to the underlying biological mechanisms and even
causality, but whether this comes through the selected variants and
their interactions, or via synthetic associations or other nondirect
relationships needs to be evaluated mechanistically. Genotype–
phenotype modeling is a highly challenging problem, but we
believe that through appropriate implementation and application
of the supervised machine learning methods, such as those
presented here, increasingly predictive relationships and biological
understanding will be extracted from the current and emerging
genetic and phenotypic datasets.
Supporting Information
Text S1 Implementation details for a range of regularized
machine learning models.
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